Updated Feb. 4, 2014 at 5:22 p.m.

Premium Lock Furiex stock soars 129% on positive test results for IBS drug

Published: 2014-02-04 11:09:00
Updated: 2014-02-04 17:22:24

Furiex Furiex

An irritable bowel syndrome drug from Furiex Pharmaceuticals (Nasdaq: FURX) met key goals in two late-stage clinical trials, results that boosted the stock price of the Morrisville drug developer 129 percent Tuesday morning....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll